A deworming medication has been found to kill cancer cells and boost the production of a cancer-killing gene. Research suggests the drug can be used in conjunction with other treatments to improve a patient’s chances of survival. The drug, fenbendazole (FZ), interferes with the way cancer cells use energy. It blocks glucose uptake, which starves them of a vital source of energy. FZ also disrupts the microtubules that keep cancer cells growing and multiplying. It can help a patient get through stage 4 cancer, which is when the cancer has spread to other parts of the body.
Fenbendazole is an established benzimidazole anthelmintic agent with a broad antiparasitic spectrum in various animal species and an excellent safety margin. The antitumor activity of this drug has been demonstrated with a wide range of cancer cell types, and its mechanism of action has been suggested to be related to its ability to inhibit the formation of microtubules by disrupting tubulin polymerization.
However, the effectiveness of fenbendazole in patients with advanced cancer is still unclear. Despite the lack of scientific proof, some people claim to have survived stage 4 cancer by using fenbendazole, along with other supplements such as curcumin and CBD. One man, Joe Tippens, was diagnosed with stage four brain cancer and given only three months to live after surgery and chemotherapy. He was able to extend his life with a regimen of fenbendazole and other supplements, which became known as the Joe Tippens Protocol. fenbendazole stage 4 cancer